An anti-SARS-CoV-2 antibody research reagent is now available from the National Institute for Biological Standards and Control (NIBSC). This follows previous work by the Institute to develop a SARS-CoV-2 RNA research reagent.
The new antibody reagent is plasma that has been treated to inactivate enveloped viruses and is derived from a donor that has recovered from COVID-19.
It is intended to be used as a positive control for the development and evaluation of serological assays that detect the presence of antibodies against SARS-CoV-2, specifically neutralisation assays and ELISAs.
Information about our additional COVID-19-related reagents and ordering instructions are available here.